Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter.
作者信息
Violet Pierre-Christian, Levine Mark
机构信息
Molecular and Clinical Nutrition Section, NIDDK, NIH, Bethesda, MD 20892, United States.
Molecular and Clinical Nutrition Section, NIDDK, NIH, Bethesda, MD 20892, United States.
出版信息
EBioMedicine. 2017 Apr;18:9-10. doi: 10.1016/j.ebiom.2017.03.014. Epub 2017 Mar 9.
Abstract
摘要
相似文献
1
Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter.骨髓瘤治疗中的药理学维生素C：剂量很重要。
EBioMedicine. 2017 Apr;18:9-10. doi: 10.1016/j.ebiom.2017.03.014. Epub 2017 Mar 9.
2
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.药理学剂量的抗坏血酸盐可作为一种促氧化剂，并减少小鼠体内侵袭性肿瘤异种移植物的生长。
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9. doi: 10.1073/pnas.0804226105. Epub 2008 Aug 4.
3
4
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.药理学浓度的抗坏血酸盐在体内细胞外液中选择性地产生抗坏血酸自由基和过氧化氢。
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8749-54. doi: 10.1073/pnas.0702854104. Epub 2007 May 14.
5
The Interrelationship of Pharmacologic Ascorbate Induced Cell Death and Ferroptosis.药理学维生素C诱导的细胞死亡与铁死亡的相互关系。
Pathol Oncol Res. 2019 Apr;25(2):669-679. doi: 10.1007/s12253-018-0539-9. Epub 2018 Nov 15.
6
Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.化妆品中使用的L-抗坏血酸、抗坏血酸钙、抗坏血酸镁、抗坏血酸磷酸镁、抗坏血酸钠和抗坏血酸钠磷酸酯的安全性评估最终报告。
Int J Toxicol. 2005;24 Suppl 2:51-111. doi: 10.1080/10915810590953851.
7
Antitumor effect of pharmacologic ascorbate in the B16 murine melanoma model.药理学维生素C在B16小鼠黑色素瘤模型中的抗肿瘤作用。
Free Radic Biol Med. 2015 Oct;87:193-203. doi: 10.1016/j.freeradbiomed.2015.06.032. Epub 2015 Jun 26.
8
Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects.通过肠胃外给药可达到药理学浓度的抗坏血酸盐，且其具有抗肿瘤作用。
Free Radic Biol Med. 2009 Jul 1;47(1):32-40. doi: 10.1016/j.freeradbiomed.2009.02.016. Epub 2009 Feb 28.
9
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.药理浓度的抗坏血酸可选择性杀死癌细胞：作为一种前药将过氧化氢输送到组织的作用。
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13604-9. doi: 10.1073/pnas.0506390102. Epub 2005 Sep 12.
引用本文的文献
1
Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment.线粒体靶向抗氧化剂在癌症预防和治疗中的当前观点
Front Cell Dev Biol. 2023 Mar 16;11:1048177. doi: 10.3389/fcell.2023.1048177. eCollection 2023.
2
Pharmacological dose ascorbic acid administration in relapsed refractory multiple myeloma patients.复发难治性多发性骨髓瘤患者的药理剂量维生素C给药
Leuk Res Rep. 2021 Nov 22;16:100281. doi: 10.1016/j.lrr.2021.100281. eCollection 2021.
3
Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review).静脉注射大剂量抗坏血酸治疗脑胶质瘤的研究进展（综述）。
Int J Oncol. 2021 Jun;58(6). doi: 10.3892/ijo.2021.5215. Epub 2021 May 6.
4
Combinatorial Therapy of High Dose Vitamin C and PARP Inhibitors in DNA Repair Deficiency: A Series of 8 Patients.大剂量维生素 C 与 PARP 抑制剂联合治疗 DNA 修复缺陷：8 例系列患者。
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420969812. doi: 10.1177/1534735420969812.
5
On the effect of vitamin C intake on human health: How to (mis)interprete the clinical evidence.关于维生素 C 摄入量对人体健康的影响：如何（错误）解读临床证据。
Redox Biol. 2020 Jul;34:101532. doi: 10.1016/j.redox.2020.101532. Epub 2020 May 23.
6
Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials.癌症临床试验中静脉注射维生素C的系统评价。
Antioxidants (Basel). 2018 Jul 12;7(7):89. doi: 10.3390/antiox7070089.
本文引用的文献
1
Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid.药物剂量的抗坏血酸能选择性杀死多发性骨髓瘤肿瘤细胞。
EBioMedicine. 2017 Apr;18:41-49. doi: 10.1016/j.ebiom.2017.02.011. Epub 2017 Feb 16.
2
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.硼替佐米联合来那度胺和地塞米松与单纯来那度胺和地塞米松治疗新诊断的无立即自体干细胞移植意向的骨髓瘤患者（SWOG S0777）：一项随机、开放标签的3期试验
Lancet. 2017 Feb 4;389(10068):519-527. doi: 10.1016/S0140-6736(16)31594-X. Epub 2016 Dec 23.
3
Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.静脉内给予抗坏血酸作为癌症治疗药物：基于药代动力学的再评估。
Antioxid Redox Signal. 2013 Dec 10;19(17):2141-56. doi: 10.1089/ars.2013.5372. Epub 2013 Jun 19.
4
Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.硼替佐米联合维生素 C 或绿茶提取物（表没食子儿茶素没食子酸酯）的抗肿瘤活性的临床前评价。
Cancer Chemother Pharmacol. 2011 Nov;68(5):1145-54. doi: 10.1007/s00280-011-1591-2. Epub 2011 Mar 13.
5
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.维生素 C：补充和替代医学从业者的静脉内使用及不良反应。
PLoS One. 2010 Jul 7;5(7):e11414. doi: 10.1371/journal.pone.0011414.
6
The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review.三氧化二砷治疗复发难治性多发性骨髓瘤的疗效：一项系统评价
Cancer Treat Rev. 2009 Aug;35(5):425-30. doi: 10.1016/j.ctrv.2009.04.007. Epub 2009 May 22.
7
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.抗坏血酸在体内抑制硼替佐米的抗肿瘤活性。
Leukemia. 2009 Sep;23(9):1679-86. doi: 10.1038/leu.2009.83. Epub 2009 Apr 16.
8
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.药理学剂量的抗坏血酸盐可作为一种促氧化剂，并减少小鼠体内侵袭性肿瘤异种移植物的生长。
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9. doi: 10.1073/pnas.0804226105. Epub 2008 Aug 4.
9
Vitamin C pharmacokinetics: implications for oral and intravenous use.维生素C的药代动力学：对口服和静脉使用的意义。
Ann Intern Med. 2004 Apr 6;140(7):533-7. doi: 10.7326/0003-4819-140-7-200404060-00010.
Zotero 插件